Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07075627 · ClinicalTrials.gov registry record
A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)
A clinical trial, sponsored by Addario Lung Cancer Medical Institute.
- Not yet
- Registry status
- 400
- Enrollment target
NCT07075627: Clinical Trial study, sponsored by Addario Lung Cancer Medical Institute.
NCT07075627 is a clinical trial that has not yet begun recruiting, run by Addario Lung Cancer Medical Institute. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07075627 has not yet begun recruiting, sponsored by Addario Lung Cancer Medical Institute.
- NOT YET RECRUITING
- Registry status
- 400 participants
- Enrollment target
Study Summary
This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. Screening and/or medical record review for symptoms associated with Lambert Eaton Myasthenic Syndrome (LEMS) will be conducted.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-09 |
| Est. Completion | 2026-12 |
What is known before NCT07075627 opens enrollment
NCT07075627 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07075627 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07075627 about?
NCT07075627 is a clinical study titled "A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)". This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. Screening and/or medical record review for symptoms associated with Lambert Eaton Myasthenic Syndrome (LEMS) will be conducted.
What is the current status of trial NCT07075627?
This trial is currently not yet recruiting. The enrollment target is 400 participants. The study started on 2025-09. Estimated completion is 2026-12.
Who is sponsoring clinical trial NCT07075627?
This trial is sponsored by Addario Lung Cancer Medical Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia